CG
MDGL icon

Colony Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Colony Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-71
Closed -$1K – 471
2015
Q4 		$1K Hold
71
– – ﹤0.01% 727
2015
Q3 		$4K Buy
+71
New +$5.12K ﹤0.01% 711

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colony Group's MDGL Position: Q1 2016 in Review

Colony Group sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2016, closing a stake of 71 shares — an estimated $1K sold.

Colony Group first reported a position in MDGL in Q3 2015 and held it in 2 quarters. The position peaked at $4K in Q3 2015. 68 funds tracked by Wall St. Rank hold MDGL as of Q1 2016.

  • Colony Group reported no remaining Madrigal Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 71 Madrigal Pharmaceuticals shares in Q1 2016, an estimated $1K.
  • Colony Group first reported a position in Madrigal Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Colony Group's Madrigal Pharmaceuticals position peaked at $4K in Q3 2015.
  • 68 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.